MK-2866 | 100 x 10 mg

SAFETY DATA SHEET

Ostarine, chemically designated as MK-2866, is a non-steroidal Selective Androgen Receptor Modulator (SARM) developed to prevent and treat muscle wasting and osteoporosis. Its mechanism of action involves high-affinity binding to androgen receptors in skeletal muscle and bone tissues, selectively stimulating anabolic activity without the androgenic effects.

Its tissue-selective profile minimizes undesirable effects on the prostate or other non-target organs. Ostarine does not undergo aromatization to estrogen and exhibits minimal hepatotoxicity, which contributes to its favorable safety profile in short-term research applications.

• Demonstrates anabolic activity in skeletal muscle tissue models, including under conditions lacking mechanical load stimulation
• Modulates bone remodeling pathways, indicating potential utility in preclinical models of reduced bone mineral density (e.g., osteopenia, osteoporosis)
• Exhibits muscle-preserving effects under simulated states of caloric deficit or musculoskeletal disuse, relevant to models of cachexia and immobilization

⚠ Important Note: This product is supplied strictly for laboratory research use only. It is not approved for human consumption or therapeutic use. Not intended to diagnose, treat, cure, or prevent any disease.